<\/p>
Dividend Stock:<\/strong> \u0936\u0941\u0915\u094d\u0930\u0935\u093e\u0930 \u0915\u094b \u0936\u0947\u092f\u0930 \u092c\u093e\u091c\u093e\u0930 \u092e\u0947\u0902 \u091c\u093e\u0930\u0940 \u0924\u0947\u091c\u0940 \u0915\u0947 \u092c\u0940\u091a \u092b\u093e\u0930\u094d\u092e\u093e \u0938\u0947\u0915\u094d\u091f\u0930 \u0915\u0940 \u0915\u0902\u092a\u0928\u0940,\u00a0\u0932\u093f\u0902\u0915\u0928 \u092b\u093e\u0930\u094d\u092e\u093e\u0938\u094d\u092f\u0942\u091f\u093f\u0915\u0932\u094d\u0938 \u0932\u093f\u092e\u093f\u091f\u0947\u0921 (Lincoln Pharmaceuticals Ltd) \u0915\u093e \u0938\u094d\u091f\u0949\u0915 \u0928\u093f\u0935\u0947\u0936\u0915\u094b\u0902 \u0915\u0947 \u0930\u0921\u093e\u0930 \u092a\u0930 \u0939\u0948\u0964 \u0926\u0930\u0905\u0938\u0932 \u0915\u0902\u092a\u0928\u0940 \u0928\u0947 Q4 \u0930\u093f\u091c\u0932\u094d\u091f \u0915\u0947 \u0938\u093e\u0925 \u0928\u093f\u0935\u0947\u0936\u0915\u094b\u0902 \u0915\u0947 \u0932\u093f\u090f \u0921\u093f\u0935\u093f\u0921\u0947\u0902\u0921 \u0915\u093e \u0910\u0932\u093e\u0928 \u0915\u093f\u092f\u093e \u0939\u0948\u0964 \u091a\u0932\u093f\u090f \u091c\u093e\u0928\u0924\u0947 \u0939\u0948\u0902 \u0939\u0930 \u0936\u0947\u092f\u0930 \u092a\u0930 \u0906\u092a\u0915\u094b \u0915\u093f\u0924\u0928\u093e \u092b\u093e\u092f\u0926\u093e \u0939\u094b\u0917\u093e?<\/p> Lincoln Pharmaceuticals Q4FY26 Results<\/strong><\/p> \u0915\u0902\u092a\u0928\u0940 \u0928\u0947 \u0905\u092a\u0928\u0947 \u092b\u093e\u0907\u0932\u093f\u0902\u0917 \u092e\u0947\u0902 \u092c\u0924\u093e\u092f\u093e \u0915\u093f\u00a0\u0935\u093f\u0924\u094d\u0924 \u0935\u0930\u094d\u0937 2026 \u092e\u0947\u0902 \u0909\u0938\u0915\u093e\u00a0\u0915\u0902\u0938\u094b\u0932\u093f\u0921\u0947\u091f\u0947\u0921 \u0928\u0947\u091f \u092a\u094d\u0930\u0949\u092b\u093f\u091f \u092c\u0922\u093c\u0915\u0930 87.89 \u0915\u0930\u094b\u0921\u093c \u0930\u0941\u092a\u092f\u0947 \u092a\u0939\u0941\u0902\u091a \u0917\u092f\u093e, \u091c\u094b FY25 \u092e\u0947\u0902 82.35 \u0915\u0930\u094b\u0921\u093c \u0930\u0941\u092a\u092f\u0947 \u0925\u093e\u0964 \u0935\u0939\u0940\u0902 \u0915\u0902\u092a\u0928\u0940 \u0915\u0940 \u0911\u092a\u0930\u0947\u0936\u0902\u0938 \u0938\u0947 \u0906\u092f 9.10% \u092c\u0922\u093c\u0915\u0930 704.48 \u0915\u0930\u094b\u0921\u093c \u0930\u0941\u092a\u092f\u0947 \u0930\u0939\u0940\u0964 EBITDA \u092d\u0940 \u092c\u0922\u093c\u0915\u0930 131.14 \u0915\u0930\u094b\u0921\u093c \u0930\u0941\u092a\u092f\u0947 \u092a\u0939\u0941\u0902\u091a \u0917\u092f\u093e \u0914\u0930 EPS 43.88 \u0930\u0941\u092a\u092f\u0947 \u092a\u094d\u0930\u0924\u093f \u0936\u0947\u092f\u0930 \u0930\u0939\u093e\u0964 \u0915\u0902\u092a\u0928\u0940 \u0915\u093e \u092a\u094d\u0930\u0949\u092b\u093f\u091f \u092c\u093f\u092b\u094b\u0930 \u091f\u0948\u0915\u094d\u0938 115.63 \u0915\u0930\u094b\u0921\u093c \u0930\u0941\u092a\u092f\u0947 \u0926\u0930\u094d\u091c \u0915\u093f\u092f\u093e \u0917\u092f\u093e\u0964<\/p> 31 \u092e\u093e\u0930\u094d\u091a 2026 \u0924\u0915 FIIs \u0915\u0940 \u0939\u093f\u0938\u094d\u0938\u0947\u0926\u093e\u0930\u0940 \u092c\u0922\u093c\u0915\u0930 5.20% \u0939\u094b \u0917\u0908, \u091c\u092c\u0915\u093f DIIs \u0915\u0940 \u0939\u093f\u0938\u094d\u0938\u0947\u0926\u093e\u0930\u0940 1.08% \u0930\u0939\u0940\u0964 \u0915\u0902\u092a\u0928\u0940 \u0928\u0947 \u092f\u0939 \u092d\u0940 \u092c\u0924\u093e\u092f\u093e \u0915\u093f \u0935\u094b\u00a0\u0905\u0917\u0932\u0947 \u0924\u0940\u0928 \u0938\u093e\u0932 \u092e\u0947\u0902 1,000 \u0915\u0930\u094b\u0921\u093c \u0930\u0941\u092a\u092f\u0947 \u0930\u0947\u0935\u0947\u0928\u094d\u092f\u0942 \u0915\u093e \u0932\u0915\u094d\u0937\u094d\u092f \u0932\u0947\u0915\u0930 \u091a\u0932 \u0930\u0939\u0940 \u0939\u0948\u0964 \u0907\u0938\u0915\u0947 \u0932\u093f\u090f \u0915\u0902\u092a\u0928\u0940 \u0915\u093e\u0930\u094d\u0921\u093f\u092f\u0915, \u0921\u093e\u092f\u092c\u093f\u091f\u093f\u0915, \u0921\u0930\u094d\u092e\u0947\u091f\u094b\u0932\u0949\u091c\u0940 \u0914\u0930 ENT \u0938\u0947\u0917\u092e\u0947\u0902\u091f \u092e\u0947\u0902 \u0935\u093f\u0938\u094d\u0924\u093e\u0930 \u0915\u0947 \u0938\u093e\u0925 \u0928\u090f \u092c\u093e\u091c\u093e\u0930\u094b\u0902 \u092e\u0947\u0902 \u090f\u0902\u091f\u094d\u0930\u0940 \u092a\u0930 \u092b\u094b\u0915\u0938 \u0915\u0930 \u0930\u0939\u0940 \u0939\u0948\u0964<\/p> \u0915\u0902\u092a\u0928\u0940 \u0915\u0947 \u0921\u093e\u092f\u0930\u0947\u0915\u094d\u091f\u0930 \u092e\u0941\u0902\u091c\u093e\u0932 \u092a\u091f\u0947\u0932 \u0928\u0947 \u0915\u0902\u092a\u0928\u0940 \u0915\u0947 \u092a\u094d\u0930\u0926\u0930\u094d\u0936\u0928 \u092a\u0930 \u0915\u0939\u093e \u0915\u093f FY26 \u0915\u0902\u092a\u0928\u0940 \u0915\u0947 \u0932\u093f\u090f \u092e\u091c\u092c\u0942\u0924 \u0917\u094d\u0930\u094b\u0925 \u0935\u093e\u0932\u093e \u0938\u093e\u0932 \u0930\u0939\u093e, \u091c\u093f\u0938\u092e\u0947\u0902 \u092c\u0947\u0939\u0924\u0930 \u0921\u093f\u092e\u093e\u0902\u0921, \u0911\u092a\u0930\u0947\u0936\u0928\u0932 \u090f\u092b\u093f\u0936\u093f\u090f\u0902\u0938\u0940 \u0914\u0930 \u0932\u0917\u093e\u0924\u093e\u0930 \u0905\u091a\u094d\u091b\u0947 \u092a\u094d\u0930\u0926\u0930\u094d\u0936\u0928 \u0915\u093e \u092c\u0921\u093c\u093e \u092f\u094b\u0917\u0926\u093e\u0928 \u0930\u0939\u093e\u0964 \u0909\u0928\u094d\u0939\u094b\u0902\u0928\u0947 \u0915\u0939\u093e \u0915\u093f \u0915\u0902\u092a\u0928\u0940 \u0905\u092a\u0928\u0947 \u092a\u094d\u0930\u094b\u0921\u0915\u094d\u091f \u092a\u094b\u0930\u094d\u091f\u092b\u094b\u0932\u093f\u092f\u094b \u0915\u094b \u092e\u091c\u092c\u0942\u0924 \u0915\u0930\u0928\u0947, \u0918\u0930\u0947\u0932\u0942 \u0914\u0930 \u0905\u0902\u0924\u0930\u0930\u093e\u0937\u094d\u091f\u094d\u0930\u0940\u092f \u092c\u093e\u091c\u093e\u0930 \u092e\u0947\u0902 \u0935\u093f\u0938\u094d\u0924\u093e\u0930 \u0915\u0930\u0928\u0947 \u0914\u0930 \u0930\u093f\u0938\u0930\u094d\u091a \u0935 \u092e\u0948\u0928\u094d\u092f\u0941\u092b\u0948\u0915\u094d\u091a\u0930\u093f\u0902\u0917 \u0915\u094d\u0937\u092e\u0924\u093e \u092c\u0922\u093c\u093e\u0928\u0947 \u092a\u0930 \u092b\u094b\u0915\u0938 \u0915\u0930 \u0930\u0939\u0940 \u0939\u0948\u0964\u00a0<\/p> Lincoln Pharmaceuticals Dividend<\/strong><\/p> Q4 \u0930\u093f\u091c\u0932\u094d\u091f \u0915\u0947 \u0938\u093e\u0925-\u0938\u093e\u0925 \u0915\u0902\u092a\u0928\u0940 \u0928\u0947 \u0928\u093f\u0935\u0947\u0936\u0915\u094b\u0902 \u0915\u0947 \u0932\u093f\u090f \u0939\u0930 \u0936\u0947\u092f\u0930 \u092a\u0930\u00a01.80 \u0930\u0941\u092a\u092f\u0947 \u0915\u093e \u0921\u093f\u0935\u093f\u0921\u0947\u0902\u0921 \u0926\u0947\u0928\u0947 \u0915\u093e \u0910\u0932\u093e\u0928 \u0915\u093f\u092f\u093e \u0939\u0948\u0964 \u0939\u093e\u0932\u093e\u0902\u0915\u093f \u0905\u092d\u0940 \u0915\u0902\u092a\u0928\u0940 \u0928\u0947 \u0907\u0938 \u0921\u093f\u0935\u093f\u0921\u0947\u0902\u0921 \u0915\u0947 \u0932\u093f\u090f \u0930\u093f\u0915\u0949\u0930\u094d\u0921 \u0921\u0947\u091f \u0915\u0940 \u0918\u094b\u0937\u0923\u093e \u0928\u0939\u0940\u0902 \u0915\u0940 \u0939\u0948\u0964\u00a0<\/p> Lincoln Pharmaceuticals Share Price<\/strong><\/p> \u0915\u0902\u092a\u0928\u0940 \u0915\u093e \u0936\u0947\u092f\u0930 \u0906\u091c \u0938\u0941\u092c\u0939 9:26 \u092c\u091c\u0947 \u0924\u0915 \u090f\u0928\u090f\u0938\u0908 \u092a\u0930\u00a010.95% \u092f\u093e\u00a083.05 \u0930\u0941\u092a\u092f\u0947 \u091f\u0942\u091f\u0915\u0930\u00a0675.10 \u0930\u0941\u092a\u092f\u0947 \u092a\u0930 \u091f\u094d\u0930\u0947\u0921 \u0915\u0930 \u0930\u0939\u093e \u0939\u0948 \u0914\u0930 \u092c\u0940\u090f\u0938\u0908 \u092a\u0930 \u0938\u094d\u091f\u0949\u0915\u00a010.37% \u092f\u093e 78.65 \u0930\u0941\u092a\u092f\u0947 \u0917\u093f\u0930\u0915\u0930\u00a0679.70 \u0930\u0941\u092a\u092f\u0947 \u092a\u0930 \u091f\u094d\u0930\u0947\u0921 \u0915\u0930 \u0930\u0939\u093e \u0925\u093e\u0964<\/p> <\/div> lincoln pharmaceuticals share price, lincoln pharmaceuticals dividend, lincoln pharmaceuticals q4 results, pharma stocks india, dividend stocks india, lincoln pharma stock news, lincoln pharmaceuticals fy26 results, lincoln pharma latest news, pharmaceutical sector stocks, lincoln pharmaceuticals earnings, lincoln pharma dividend announcement, lincoln pharmaceuticals revenue growth, lincoln pharma net profit, pharma company dividend stock, stock in focus india, lincoln pharma share analysis, indian pharma stocks, lincoln pharmaceuticals eps, lincoln pharmaceuticals ebitda, pharma sector investment india, multibagger pharma stock, lincoln pharmaceuticals investor news, healthcare stocks india, lincoln pharmaceuticals expansion plans, pharma stocks with dividend, lincoln pharma financial results, indian stock market news, best dividend paying pharma stocks, lincoln pharmaceuticals target, fii holding in lincoln p#Dividend #Stock #\u0928\u0924\u091c #\u0915 #\u0938\u0925 #\u0907\u0938 #\u092b\u0930\u092e #\u0915\u092a\u0928 #\u0928 #\u0915\u092f #\u0921\u0935\u0921\u0921 #\u0915 #\u0910\u0932\u0928 #\u091c\u0928 #\u0939\u0930 #\u0936\u092f\u0930 #\u092a\u0930 #\u0915\u0924\u0928 #\u0939\u0917 #\u092b\u092f\u09261780150412<\/p> ","protected":false},"excerpt":{"rendered":" Dividend Stock: \u0936\u0941\u0915\u094d\u0930\u0935\u093e\u0930 \u0915\u094b \u0936\u0947\u092f\u0930 \u092c\u093e\u091c\u093e\u0930 \u092e\u0947\u0902 \u091c\u093e\u0930\u0940 \u0924\u0947\u091c\u0940 \u0915\u0947 \u092c\u0940\u091a \u092b\u093e\u0930\u094d\u092e\u093e \u0938\u0947\u0915\u094d\u091f\u0930 \u0915\u0940 \u0915\u0902\u092a\u0928\u0940,\u00a0\u0932\u093f\u0902\u0915\u0928 \u092b\u093e\u0930\u094d\u092e\u093e\u0938\u094d\u092f\u0942\u091f\u093f\u0915\u0932\u094d\u0938 \u0932\u093f\u092e\u093f\u091f\u0947\u0921 (Lincoln Pharmaceuticals Ltd) \u0915\u093e \u0938\u094d\u091f\u0949\u0915 \u0928\u093f\u0935\u0947\u0936\u0915\u094b\u0902 \u0915\u0947 \u0930\u0921\u093e\u0930 \u092a\u0930 \u0939\u0948\u0964 \u0926\u0930\u0905\u0938\u0932 \u0915\u0902\u092a\u0928\u0940 \u0928\u0947 Q4 \u0930\u093f\u091c\u0932\u094d\u091f \u0915\u0947 \u0938\u093e\u0925 \u0928\u093f\u0935\u0947\u0936\u0915\u094b\u0902 \u0915\u0947 \u0932\u093f\u090f \u0921\u093f\u0935\u093f\u0921\u0947\u0902\u0921 \u0915\u093e \u0910\u0932\u093e\u0928 \u0915\u093f\u092f\u093e \u0939\u0948\u0964 \u091a\u0932\u093f\u090f \u091c\u093e\u0928\u0924\u0947 \u0939\u0948\u0902 \u0939\u0930 \u0936\u0947\u092f\u0930 \u092a\u0930 \u0906\u092a\u0915\u094b \u0915\u093f\u0924\u0928\u093e \u092b\u093e\u092f\u0926\u093e \u0939\u094b\u0917\u093e? Lincoln Pharmaceuticals Q4FY26 […]<\/p>\n","protected":false},"author":1,"featured_media":9013,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[34894,1769,16834,34896,8036,34885,1462,34880,34893,34877,34882,34884,34875,34872,34879,34887,34886,34891,34876,34890,34873,34881,34871,34895,34889,34883,34888,34874,34892,34878,2121,34833,288,4442,138,2172,289,732,1245,9593,727,5590,285,6441,7093,290,1262,3302,5963],"class_list":["post-9012","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-content-marketing","tag-best-dividend-paying-pharma-stocks","tag-dividend","tag-dividend-stocks-india","tag-fii-holding-in-lincoln-p","tag-healthcare-stocks-india","tag-indian-pharma-stocks","tag-indian-stock-market-news","tag-lincoln-pharma-dividend-announcement","tag-lincoln-pharma-financial-results","tag-lincoln-pharma-latest-news","tag-lincoln-pharma-net-profit","tag-lincoln-pharma-share-analysis","tag-lincoln-pharma-stock-news","tag-lincoln-pharmaceuticals-dividend","tag-lincoln-pharmaceuticals-earnings","tag-lincoln-pharmaceuticals-ebitda","tag-lincoln-pharmaceuticals-eps","tag-lincoln-pharmaceuticals-expansion-plans","tag-lincoln-pharmaceuticals-fy26-results","tag-lincoln-pharmaceuticals-investor-news","tag-lincoln-pharmaceuticals-q4-results","tag-lincoln-pharmaceuticals-revenue-growth","tag-lincoln-pharmaceuticals-share-price","tag-lincoln-pharmaceuticals-target","tag-multibagger-pharma-stock","tag-pharma-company-dividend-stock","tag-pharma-sector-investment-india","tag-pharma-stocks-india","tag-pharma-stocks-with-dividend","tag-pharmaceutical-sector-stocks","tag-stock","tag-stock-in-focus-india","tag-288","tag-4442","tag-138","tag-2172","tag-289","tag-732","tag-1245","tag-9593","tag-727","tag-5590","tag-285","tag-6441","tag-7093","tag-290","tag-1262","tag-3302","tag-5963"],"acf":[],"_links":{"self":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/posts\/9012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9012"}],"version-history":[{"count":0,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/posts\/9012\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/media\/9013"}],"wp:attachment":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9012"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}